Angiogenesis Modulating Agents

Agents that modulate the PHYSIOLOGIC ANGIOGENESIS process. This is accomplished by endogenous ANGIOGENIC PROTEINS and a variety of other chemicals and pharmaceutical agents.

Also Known As:

Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Cao, Yihai: 3 articles (01/2014 - 01/2009)
2.	Lim, Sharon: 2 articles (05/2010 - 01/2009)
3.	Xue, Yuan: 2 articles (05/2010 - 01/2009)
4.	Breitbart, R E: 2 articles (12/2001 - 12/2001)
5.	Donovan, M J: 2 articles (12/2001 - 12/2001)
6.	Ginsburg, G S: 2 articles (12/2001 - 12/2001)
7.	Ross, J S: 2 articles (12/2001 - 12/2001)
8.	Stagliano, N E: 2 articles (12/2001 - 12/2001)
9.	Araujo Júnior, Edward: 1 article (02/2016)
10.	Da Silva Costa, Fabricio: 1 article (02/2016)

Related Diseases

1.	Neurofibrosarcoma (MPNST) 09/01/1990 - "These studies suggest that angiogenesis modulators are worthy of further study as feasible means of treating human neurofibrosarcoma."
2.	Neoplasms (Cancer) 09/01/2012 - "The discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. " 12/01/2001 - "Angiogenesis modulators have been linked to plaque expansion and restenosis of atherosclerotic lesions and to local and metastatic tumor expansion." 12/01/2001 - "Angiogenesis modulators have recently been linked to plaque expansion and restenosis of atherosclerotic lesions as well as local and metastatic tumor expansion. " 10/01/2000 - "In the last few years, the discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. "
3.	Obesity 01/01/2014 - "Given the therapeutic values of angiogenesis modulators in preclinical animal models, it is reasonable to speculate these angiogenesis modulators may eventually be used for treatment of human obesity and metabolic disorders." 05/01/2010 - "In the view of the crucial roles of vasculature in modulation of adipogenesis and obesity, this protocol is valuable for studying the molecular mechanisms of angiogenesis in obese adipose tissues and for assessing the anti-obesity activity of angiogenesis modulators." 01/07/2009 - "Our findings have conceptual implications concerning application of angiogenesis modulators for treatment of obesity and metabolic disorders."
4.	Posterior Leukoencephalopathy Syndrome 10/01/2006 - "Reversible posterior leukoencephalopathy syndrome following treatment with angiogenesis modulators can occur. "
5.	Disease Progression 07/01/2005 - "We sought to determine whether these angiogenesis modulators are present in the urine and whether their expression is associated with the extent and clinical course of the vascular lesion. "